BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Ambry Names Tom Schoenherr as Chief Commercial Officer

  Tom’s primary role will be to build upon Ambry’s success in the genetic testing space following the successful acquisition by Konica Minolta.

  December 14, 2017

   · 

  3 min read
• Business

  Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors

  Protagonist Therapeutics today announced the appointment of Sarah Noonberg, M.D., Ph.D., CMO of Prothena, to the Protagonist Board of Directors.

  December 14, 2017

   · 

  5 min read
• 

  Drug Development

  Ampio’s Osteoarthritis Drug Meets All Endpoints in Phase III Study

  If approved, Ampion would be the first intra-articular injection to treat the signs and symptoms of patients with severe osteoarthritis of the knee.

  December 14, 2017

   · 

  6 min read
• Business

  Nuvo Pharma Enters Into Pennsaid 2% License Agreement With Gebro Pharma AG for Switzerland and Liechtenstein

  The License Agreement grants Gebro Pharma the exclusive rights throughout the Territory to register, market, sell and distribute Pennsaid 2% as a non-prescription drug for the human treatment of osteoarthritis of the knee and acute pain from sprains and strains.

  December 14, 2017

   · 

  5 min read
• MediaTek Sensio: New Biosensor Solution Brings Health Monitoring to Smartphones

  MediaTek Sensio is a powerful advanced health monitoring solution which makes it easy to track heart rate information, blood pressure trends, peripheral oxygen saturation levels and more.

  December 14, 2017

   · 

  4 min read
• Business

  KalVista Pharmaceuticals Reports Fiscal Second Quarter Results

  Revenue was $1.1 million for the three months ended October 31, 2017, compared to $0.2 million for the same period in 2016.

  December 14, 2017

   · 

  8 min read
• Drug Development

  Trovagene Submits Protocol to FDA for Phase II Clinical Trial of PCM-075 in Combination With Zytiga for Metastatic Castration-Resistant Prostate Cancer

  In this multi-center, open-label, Phase 2 trial, PCM-075 in combination with the standard dose of abiraterone and prednisone, all administered orally, will be evaluated for safety and efficacy.

  December 14, 2017

   · 

  8 min read
• FDA

  Medimetriks Pharma Receives FDA Approval for Xepi (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

  The approval of Xepi is based on a clinical development program that includes the results of two phase 3 trials.

  December 14, 2017

   · 

  5 min read
• Pharm Country

  Advaxis to Host Business Update and Fiscal Year End 2017 Financial Results Conference Call on December 21, 2017

  The conference call and live audio webcast will begin at 10:00 a.m. Eastern time on Thursday, December 21, 2017.

  December 14, 2017

   · 

  3 min read
• Biotech Beach

  DermTech Announces JAMA Dermatology Publication Highlighting the PLA Utility

  The PLA tool helped the dermatologist to correctly diagnose melanoma in a patient who was reluctant to receive a surgical biopsy.

  December 14, 2017

   · 

  2 min read